Original Investigation

Intravenous Immunoglobulin Add-On in Newly Diagnosed Idiopathic Inflammatory Myopathies

JAMA Neurology 10.1001/jamaneurol.2026.3088

September 14, 2026 at 11:00 AM EDT

Read the full article

Adult patients with newly diagnosed IIMs treated with IVIG in addition to standard high-dose prednisone showed greater and faster improvement compared to patients who received standard high-dose prednisone.

Corresponding Author: Joost Raaphorst, MD, PhD, Department of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, University of Amsterdam, Meibergdreef 9, Amsterdam 1105 AZ, the Netherlands (j.raaphorst@amsterdamumc.nl).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2026.3088?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091426

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks